Processing your payment...
Please do not close your browser.

Catalog Peptides Market Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players- PolyPeptide Group, CSBio, GL Biochem (Shanghai) Ltd., CPC Scientific Inc., Auspep Pty Ltd., Peptides International

03 Jun, 2022 | 123 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Acknowledging the kind of traction gained by this market, recently published a study report by industry data analytics asserts the Global Catalog Peptides Market size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of 5.12% during the review period (2022 to 2027).



Global Catalog Peptides Market Overview



The Catalog Peptides Marketplace report provides a holistic appraisal of the market for the forecast period. The report includes various segments as well as an analysis of the trends and factors that are playing a substantial role in the market. These factors; the market subtleties, involves the drivers, restraints, opportunities, and tests through which the impact of these factors in the market is outlined. The drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market. The Global Catalog Peptides Market study delivers an outlook on the expansion of the market in terms of revenue throughout the prognosis period.



The catalogue peptide market is seeing growth due to technical loans that aid in the lucrative production of peptides. Previously, peptides were manufactured from natural sources such as porcine-derived adrenocorticotropic hormone (ACTH) or bovine pituitary, and bovine or canine pancreatic insulin. Growing investigate activities to address unmet medical needs in various therapeutic areas, raising the burden of chronic illnesses and increasing asset and funding for protein-based research are among the key factors driving the market growth. Nevertheless, the absence of a coherent collection of regulations restrains business development.



Who are the Prime Players in Global Catalog Peptides Market?



The Global Catalog Peptides Market includes identification and analysis of the various market participants competing in the global market. Prime competitors include PolyPeptide Group, CSBio, GL Biochem (Shanghai) Ltd., CPC Scientific Inc., Auspep Pty Ltd., Peptides International Inc., Applied Biological Materials (ABM) Inc., Biomatik Corporation, Bio-Synthesis Inc., Thermo Fisher Scientific Inc., GenScript Biotech Corporation, Bachem AG, JPT Peptide Technologies GmbH, Advanced ChemTech, LifeTein LLC, Kaneka Eurogentec S.A., Elim Biopharm Inc., Creative Peptides, Abbiotec Inc., NovoPro Bioscience Inc., KareBay Biochem Inc., Ontores Biotechnologies Inc., Severn Biotech Ltd., Genway Biotech Inc., Kaneka Corporation, New England Peptide Inc., AnaSpec Inc., AAPPTec LLC, and Merck KGaA.



Industry News and Updates:



Nov. 11, 2021: GenScript Launches Closed-End Double-Stranded DNA Service for CRISPR



GenScript USA Inc., the world’s leading life science research tools and services provider, announced today that it has launched the GenWand™ Double-Stranded DNA (dsDNA) Service for the manufacture of CRISPR knock-in homology- directed repair (HDR) templates in T cell engineering.



April 22, 2022: JPT Launches Broad Spectrum of COVID-19 Peptide Tools for Immune Monitoring, Vaccine & Diagnostics Development



JPT Peptide Technologies (JPT) announces the launch of ready-to-use peptide tools to study and profile the immune response towards SARS-CoV-2 infection.




What are the major Applications, Types and Regions for Global Catalog Peptides Market?



Market is segmented based on the type, applications, companies and regions.



By Types, it is segmented into




  • Purity: 95% to 98%

  • Purity: Above 98%



By Application, it is segmented into




  • Commercial

  •  Academic Research

  •  Others



Global Catalog Peptides Market Regional Analysis



The market is bifurcated into North America, Europe, Asia Pacific, and RoW. North America accounted for the largest market share in 2018 and is expected to remain the largest market during the forecast period. The growing initiatives for governments funding for the advancement of activities such as drug discovery, antibody production, and disease research are aiding the growth of the catalog peptides market in this region.




  • North America


    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  •  Rest of the World

    • Middle East & Africa

    • Latin America





The Global Catalog Peptides Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Catalog Peptides Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.



What is our Global Catalog Peptides Market scope?























































Report Attributes



Report Details



Forecast Period 2022 to 2028 CAGR



CAGR of 5.12% during the review period (2022 to 2027).



By Types




  • Purity: 95% to 98%

  • Purity: Above 98%



By Application




  • Commercial

  •  Academic Research

  •  Others



By Companies



PolyPeptide Group, CSBio, GL Biochem (Shanghai) Ltd., CPC Scientific Inc., Auspep Pty Ltd., Peptides International



Regions Covered




  • North America

  • Europe

  • Asia-Pacific

  • Rest of the World



Countries Covered




  • US

  • Canada

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • Middle East & Africa

  • Latin America



Base Year



      2022



Historical Year



       2017 to 2021



Forecast Year



      2022 to 2027



Number of Pages



    123



Customization Available



Yes, the report can be customized as per your needs




 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



Growth Drive –



The catalog peptides market is witnessing rapid evolution with the expansion of new peptide and drug production knowledges. For instance, growth in the number of researches to appreciate the well-organized appearance of novel and difficult-to-express proteins, through protein and cell line engineering, can be viewed as a step toward future drug discoveries. Due to the increasing research activities focusing on the unmet needs for various chronic diseases, such as diabetes, cancer, ischemic heart disease, and respiratory disorders, administration and national organizations/bodies are providing improved funding to research institutes for the development of new cost-effective drugs.



Frequently Asked Question



What is the study period of this market?



The Global Catalog Peptides Market is studied from 2022-2027.



Who are the prime players in the Global Catalog Peptides Market?



Poly Peptide Group, CSBio, GL Biochem (Shanghai) Ltd., CPC Scientific Inc., Auspep Pty Ltd., Peptides International



Which region held the largest share in the Global Catalog Peptides Market?



United States, Europe, China, Japan, Southeast Asia, India and Rest of World



What are the significant Types of   Global Catalog Peptides Market?



Purity: 95% to 98%, Purity: Above 98%



What are the major Application of   Global Catalog Peptides Market?



Commercial, Academic Research, Others


  1. INTRODUCTION

    1. MARKET DEFINATION

    2. MARKET DYNAMICS

    3. MARKET SEGMENTATION

    4. REPORT TIMLINES

    5. KEY STAKEHOLDERS



  2. RESEARCH METHODOLOGY

    1. DATA MINING

      1. SECONDARY RESEARCH

      2. PRIMARY RESEARCH

      3. SUBJECT MATTER EXPERT ADVICE



    2. QUALITY CHECK

    3. FINAL REVIEW

      1. DATA TRIANGULATION

      2. BOTTOM-UP APPROACH

      3. TOP-DOWN APPROACH



    4. RESEARCH FLOW



  3. EXECUTIVE SUMMARY

    1. INTRODUCTION

    2. GLOBAL CATALOG PEPTIDES MARKET BY TYPE

    3. GLOBAL CATALOG PEPTIDES MARKETBY APPLICTAION



  4. GLOBAL CATALOG PEPTIDES MARKETDYNAMICS

    1. DRIVERS

    2. INCREASING LENSMETER MARKET

    3. RESTRAINTS

      1. STRINGENT ENVIRONMENTAL REGUALTIONS

      2. HIGH COST ON MATERIALS



    4. OPPORTUNITIES

      1. LENSMETER MARKETGROWTH



    5. APPLICATION OF CATALOG PEPTIDES MARKETIMPACT OF COVID-19



  5. GLOBAL CATALOG PEPTIDES MARKET, BY DRUG TYPE



      1. INTRODUCTION

      2. PURITY: 95% TO 98%

      3. PURITY: ABOVE 98%





  6. GLOBAL CATALOG PEPTIDES MARKETAPPLICATION




  1. INTRODUCTION

  2. COMMERCIAL

  3.  ACADEMIC RESEARCH

  4.  OTHERS

  5. GLOBAL CATALOG PEPTIDES MARKETBY REGION

    1. NORTH AMERICA

      1. US

      2. CANADA

      3. MEXICO



    2. EUROPE

      1. GERMANY

      2. FRANCE

      3. UK

      4. ITALY

      5. RUSSIA

      6. REST OF EUROPE



    3. APAC

      1. CHINA

      2. SOUTH KOREA

      3. JAPAN

      4. INDIA

      5. AUSTRALIA

      6. ASEAN

      7. REST OF APAC



    4. MIDDLE EAST & AFRICA

      1. SAUDI ARABIA

      2. UAE

      3. SOUTH AFRICA

      4. TURKEY

      5. REST OF MEA



    5. SOUTH AMERICA

      1. BRAZIL

      2. REST OF MEA

      3. ARGENTINA

      4. REST OF SOUTH AMERICA





  6. COMPETITIVE LANDSCAPE

    1. MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,

    2. AND AGREEMENTS

      1. KEY DEVELOPMENT



    3. MARKET SHARE (%) **/RANKING ANALYSIS

    4. STRATEGIES ADOPTED BY LEADING PLAYERS



  7. COMPANY PROFILES

    • BUSINESS OVERVIEW

    • COMPANY SNAPSHOT

    • PRODUCT BENCHMARKING

    • STRATEGIC INITIATIVES

      1. POLYPEPTIDE GROUP,

      2. CSBIO,

      3. GL BIOCHEM (SHANGHAI) LTD.,

      4. CPC SCIENTIFIC INC.,

      5. AUSPEP PTY LTD.,

      6. PEPTIDES INTERNATIONAL INC.,

      7. APPLIED BIOLOGICAL MATERIALS (ABM) INC.,

      8.  BIOMATIK CORPORATION,

      9. BIO-SYNTHESIS INC.,

      10.  THERMO FISHER SCIENTIFIC INC.,

      11. GENSCRIPT BIOTECH CORPORATION,

      12. BACHEM AG,

      13.  JPT PEPTIDE TECHNOLOGIES GMBH,

      14. ADVANCED CHEMTECH,

      15. LIFETEIN LLC,

      16. KANEKA EUROGENTEC S.A.,

      17. ELIM BIOPHARM INC.,

      18. CREATIVE PEPTIDES,

      19. ABBIOTEC INC.,

      20. NOVOPRO BIOSCIENCE INC.,

      21.  KAREBAY BIOCHEM INC.,

      22. ONTORES BIOTECHNOLOGIES INC.,

      23. SEVERN BIOTECH LTD.,

      24. GENWAY BIOTECH INC.,

      25. KANEKA CORPORATION,

      26. NEW ENGLAND PEPTIDE INC.,

      27. ANASPEC INC.,

      28. AAPPTEC LLC, AND

      29. MERCK KGAA.





SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Merck
  • IBM
  • Dow
  • Henkel
  • AirBus
  • Cummins
  • Intel
  • Sony
  • 9
  • 3M